* 中国康哲药业0867.HK周二早盘高开1.3%，随后涨幅扩大至5.4%。
* 该公司此前公告称，CMS-D001片获得中国国家药品监督管理局同意开展临床试验以评价CMS-D001治疗特应性皮炎的安全性和有效性。
* 康哲药业今年迄今劲涨72.7%，同期恒生指数.HSI大幅上扬21.4%。
* 恒生综合行业指数 - 医疗保健业.HSCIH盘中一度升1.3%。（完）
更多股市简讯请点选CN-CMN-HOT
(发稿 徐凯文；审校 林高丽)
((kaiwen.xu@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.